从长椅到床边,在抗炎疗法中使用博斯韦利克酸 - - 机械学见解,生物可用性挑战和优化方法
Chuhang Peng1,2, Yujia Yang1,2, Yuzhi Wang1,2
1Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Frontiers in pharmacology
|December 4, 2025
概括
博斯韦利克酸 (BAs) 通过向多个途径和免疫细胞,表现出强大的抗炎作用. 研究正在推进输送系统,以提高其治疗用途的生物利用性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
- 免疫学 免疫学 免疫学
背景情况:
- 博斯韦利克酸 (BAs) 是来自博斯韦利亚物种的五环三基,具有显著的抗炎性质.
- 它们的机制包括调节关键的炎症信号通路和免疫反应.
研究的目的:
- 综合审查BA的抗炎作用.
- 从分子模拟和传递系统的进步中探索结构洞察力.
- 应对挑战,并为临床翻译提供平衡的视角.
主要方法:
- 综合临床前和临床研究的文献综述.
- 对信号通路 (NF-κB,MAPK,5-LOX,COX-2,NLRP3炎症体) 的分析.
- 分子对接,动态模拟和新型药物输送系统的概述.
主要成果:
- BA调节多种炎症途径,细胞因子,免疫细胞和氧化应激.
- 分子模拟提供了对BA-蛋白相互作用的结构洞察.
- 纳米粒子和植物体等传递系统的进步旨在克服生物可用性问题.
结论:
- 博斯韦利克酸具有具有治疗潜力的多目标免疫调节作用.
- 提高溶解度和生物可用性对于临床转化至关重要.
- 需要进一步的研究来优化BA用于治疗开发.
相关概念视频
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
155
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
155
Drugs for Treatment of Ulcerative Colitis in IBD
431
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
431
Inflammatory Bowel Disease IV: Pharmacological Management
450
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
450
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
184
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
184
Bioavailability Enhancement: Drug Permeability Enhancement
176
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
176
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
480
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
480


